Fact Check: All 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma to resolve litigation over the opioid crisis.

Fact Check: All 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma to resolve litigation over the opioid crisis.

Published June 17, 2025
VERDICT
True

# Fact Check: "All 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma to resolve litiga...

Fact Check: "All 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma to resolve litigation over the opioid crisis."

What We Know

The claim that all 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma is supported by multiple sources. On June 16, 2025, it was reported that all 55 attorneys general from the eligible states and territories reached an agreement with Purdue Pharma and the Sackler family, the owners of the company, to settle litigation related to the opioid crisis (source-2, source-4). The settlement is designed to provide funds for addiction treatment, prevention, and recovery services across the nation.

The total settlement amount is $7.4 billion, which includes significant payments from both Purdue Pharma and the Sackler family. Specifically, the Sacklers are set to pay $1.5 billion, while Purdue will contribute approximately $900 million in the first year, followed by additional payments over the next three years (source-1).

Analysis

The evidence supporting the claim is robust, with multiple reputable sources confirming the agreement among all 50 states, Washington D.C., and four U.S. territories. The announcement was made by various state attorneys general, including Michigan's Dana Nessel, who emphasized the importance of holding Purdue accountable for its role in the opioid epidemic (source-2). Additionally, New York Attorney General Letitia James also confirmed that every state has joined the settlement (source-3).

The sources used for this fact-check are credible, including official government announcements and reputable news outlets like NPR and Reuters, which have reported on the settlement's details and its implications for addressing the opioid crisis (source-4, source-5). These sources are known for their journalistic integrity and fact-checking processes, lending further credibility to the information presented.

Conclusion

Verdict: True
The claim that all 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma is accurate. The agreement has been confirmed by multiple authoritative sources, including state attorneys general and reputable news organizations, and it aims to address the significant public health crisis caused by the opioid epidemic.

Sources

  1. Carr: Georgia Joins National Settlement with Purdue Pharma ... Georgia.gov
  2. AG Nessel Signs On to $7.4 Billion Purdue Pharma ... Michigan.gov
  3. Letitia James - New York State Attorney General New York AG
  4. Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement NPR
  5. Purdue Pharma $7.4 billion opioid settlement wins broad support from US ... Reuters
  6. States agree to $7.4 billion settlement with Purdue Pharma in opioid ... ABC News
  7. All states, territories agree to $7.4B Purdue Pharma opioid settlement The Hill
  8. All states, territories agree to $7.4B Purdue Pharma opioid settlement MSN

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: Actually crime rates are higher in red states then blue states.
Partially True
🎯 Similar

Fact Check: Actually crime rates are higher in red states then blue states.

Detailed fact-check analysis of: Actually crime rates are higher in red states then blue states.

Aug 18, 2025
Read more →
Fact Check: An American soldier exposed who's really giving the orders to shoot children at Gaza aid sites.
IDF Soldiers Over Americans
Unverified
🎯 Similar

Fact Check: An American soldier exposed who's really giving the orders to shoot children at Gaza aid sites. IDF Soldiers Over Americans

Detailed fact-check analysis of: An American soldier exposed who's really giving the orders to shoot children at Gaza aid sites. IDF Soldiers Over Americans

Aug 17, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Did American veterans get arrested in DC legally protesting Trump  taking over dc
Unverified

Fact Check: Did American veterans get arrested in DC legally protesting Trump taking over dc

Detailed fact-check analysis of: Did American veterans get arrested in DC legally protesting Trump taking over dc

Aug 14, 2025
Read more →
Fact Check: All 50 states, Washington D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma to resolve litigation over the opioid crisis. | TruthOrFake Blog